LAST CHANCE: REGISTER BY MAY 20 TO SAVE UP TO $300
- 00Days
- 00Hrs
- 00Mins
- 00Secs
June 14-16, 2022
Delivered as a Hybrid EventIntercontinental Mark Hopkins Hotel, San Francisco, Californiakeyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day 3 - PST/PDT (Pacific Daylight, GMT-7)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
Day 3 - PST/PDT (Pacific Daylight, GMT-7)
search
Streams
Formats
9:00am - 9:15am15 mins
CONFERENCE THREE - June 16th
Chairperson’s Opening Remarks
9:15am - 9:45am30 mins
CONFERENCE THREE - June 16th
Keynote: A First-In-Kind, Allogeneic EBV-Targeted T-Cell Immunotherapy Approach to Treating Multiple Sclerosis
- Cokey Nguyen - SVP and Chief Scientific Officer, Atara Biotherapeutics Inc
9:45am - 10:15am30 mins
CONFERENCE THREE - June 16th
Update on CAR-M
- Nick Minutolo - Scientist II, Carisma Therapeutics Inc., USA
10:15am - 10:45am30 mins
CONFERENCE THREE - June 16th
Gamma Delta
- John Maher - CSO, Leucid Bio, Clinical Senior Lecturer in Immunology, Kings College London
10:45am - 11:30am45 mins
CONFERENCE THREE - June 16th
Refreshment Break
11:30am - 12:00pm30 mins
CONFERENCE THREE - June 16th
CAR T Cells as a Treatment for Lupus
- Marko Radic - Associate Professor, Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center
12:00pm - 12:30pm30 mins
CONFERENCE THREE - June 16th
Preclinical Efficacy and Safety Evaluation of DLL3 CAR T
- Yi Zhang - Senior Principal Scientist & Project Lead, Allogene Therapeutics, USA
12:30pm - 1:30pm60 mins
CONFERENCE THREE - June 16th
Networking Luncheon & End of Conference
Get the latest news.
As it happens
Sign up to get the latest on the agenda and speakers.
Filter
Streams
Formats